Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff

4. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders In Q3 2024: 106

Eli Lilly and Company (NYSE:LLY) is one of the biggest pharmaceutical companies in the world. Over the past five years, its shares have gained a whopping 476% as they have been driven by the firm’s weight loss drugs. Eli Lilly and Company (NYSE:LLY) has also been a regular feature of Cramer’s morning show this year. The host has remained optimistic about the company despite weak product launches and shaky fourth-quarter results. He believes Eli Lilly and Company (NYSE:LLY)’s weight loss drugs are superior to rival Novo Nordisk’s products. Here are his latest remarks:

“I urge people to remember that Lilly has some, there was a note on Friday about Lilly and GLP. They’re much more further ahead than Novo. I think Novo was a bit of a short squeeze.

“I would that in the terms of persistence, that if David Ricks were here, he’s such a great spokesperson for the industry. I think he would say, uh, it’s longer, the persistence is twelve to fifteen months. And that is what, I had to ask him directly, I said listen I keep hearing that people, because Michael Semblance had a piece, about how people leave it. He said listen that’s not right. The piece isn’t right. And I mean I do not want to dispute, you don’t want to dispute David Ricks. He’s, uh, money good, so to speak.”